Steven G. Achinger

发表

Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia.

A. Arieff, J. Ayus, S. Achinger, 2008, American journal of physiology. Renal physiology.

Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study.

A. Go, R. Thadhani, Shuko Lee, 2005, Journal of the American Society of Nephrology : JASN.

Hypertonic saline for the treatment of symptomatic hyponatremia: when is the addition of DDAVP necessary?

J. Ayus, S. Achinger, Steven G. Achinger, 2021, The American journal of the medical sciences.

Chronicity of Uncorrected Hyponatremia and Clinical Outcomes in Older Patients Undergoing Hip Fracture Repair

A. Go, S. Waikar, M. Moritz, 2020, Frontiers in Medicine.

Treatment of Hyponatremic Encephalopathy in the Critically Ill

J. Ayus, S. Achinger, Steven G. Achinger, 2017, Critical care medicine.

Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL.

A. Go, A. Arieff, F. Valderrábano, 2005, Kidney international.

The role of daily dialysis in the control of hyperphosphatemia.

J. Ayus, S. Achinger, Steven G. Achinger, 2005, Kidney international. Supplement.

Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?

J. Ayus, S. Achinger, Steven G. Achinger, 2006, Journal of the American Society of Nephrology : JASN.

Phosphorus balance and mineral metabolism with 3 h daily hemodialysis.

G. Chertow, J. Ayus, S. Achinger, 2007, Kidney international.

Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals

N. Bodyak, P. Kang, R. Thadhani, 2007, Proceedings of the National Academy of Sciences.

Dysnatremias: why are patients still dying?

M. Moritz, J. Ayus, S. Achinger, 2006, Southern medical journal.

Transplant nephrectomy improves survival following a failed renal allograft.

A. Go, M. Sayegh, Shuko Lee, 2010, Journal of the American Society of Nephrology.

When the source of inflammation is hiding in plain sight: Failed kidney transplants, clotted arteriovenous grafts, and central venous catheters

J. Ayus, S. Achinger, Steven G. Achinger, 2018, Seminars in dialysis.

Getting it Straight: Avoiding Blunders While Criticizing a Peer's Work.

A. Go, J. Ayus, S. Achinger, 2016, International journal of epidemiology.

Inflammation from dialysis, can it be removed?

J. Ayus, Steven G. Achinger, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Editorial Focus: Transplant Nephrectomy: At the Peril of Dialysis Patients: Ignoring the Failed Transplant

J. Ayus, S. Achinger, Steven G. Achinger, 2005, Seminars in dialysis.

Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series.

K. Kalantar-Zadeh, A. Arieff, J. Ayus, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

ESSENTIAL PHYSIOLOGIC CONCERNS CHAPTER 41 ■ FLUIDS AND ELECTROLYTES

J. Ayus, S. Achinger, Steven G. Achinger, 2010 .

Dysnatremias: Diagnosis and Treatment

J. Ayus, S. Achinger, Steven G. Achinger, 2008 .

Long‐term effects of daily hemodialysis on vascular access outcomes: A prospective controlled study

T. Ikizler, A. Shintani, A. Bian, 2013, Hemodialysis international. International Symposium on Home Hemodialysis.

Use of Desmopressin in Hyponatremia: Foe and Friend

J. Ayus, S. Achinger, Steven G. Achinger, 2019, Kidney medicine.

The role of vitamin D in left ventricular hypertrophy and cardiac function.

J. Ayus, S. Achinger, Steven G. Achinger, 2005, Kidney international. Supplement.

Long term reduction of cardiovascular risk factors associated with three hour daily dialysis: A prospective, cohort study

J. Ayus, S. Achinger, Steven G. Achinger, 2023, Hemodialysis international. International Symposium on Home Hemodialysis.

Use of 3‐hour daily hemodialysis and paricalcitol in patients with severe secondary hyperparathyroidism: A case series

J. Ayus, S. Achinger, M. Mizani, 2010, Hemodialysis international. International Symposium on Home Hemodialysis.